#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autologous haematopoietic stem cell transplant Neurofibroma Superficial vein thrombosis Antiphospholipid syndrome Lennox-Gastaut syndrome Sickle cell disease Mucopolysaccharidosis I Thermal burn Pneumonia B-cell small lymphocytic lymphoma Cutaneous T-cell lymphoma stage I Ovarian epithelial cancer Fungal infection Angiosarcoma Basal cell naevus syndrome More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome Inclusion body myositis – Basic Information MELAS syndrome Undifferentiated sarcoma – Diagnostics Choroid melanoma – Life with Disease Burkitt’s lymphoma – Diagnostics Aicardi-Goutieres syndrome Pleomorphic leiomyosarcoma – Diagnostics MELAS syndrome – Life with Disease Hairy cell leukaemia recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cefoxitin Sodium Flupentixol Decanoate CEFTAROLINE FOSAMIL Triptorelin Pamoate Golexanolone ACT-1004-1239 Amoxicillin Trihydrate Treosulfan Faricimab Tegafur Prednisone Ponsegromab Alitretinoin Pimozide SP16 PIPOTIAZINE Ceftazidime ZAMPILIMAB Magnesium Citrate Ivacaftor More therapies…

    Learn about Your Condition

    Systemic sclerosis pulmonary Haemolytic uraemic syndrome Neuropathic arthropathy Invasive breast carcinoma Hypophosphatasia Hyperadrenocorticism Vasospasm Alagille syndrome Skin ulcer Altered state of consciousness Candida infection Diphtheria Metastatic gastric cancer Ligament operation Ejection fraction normal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Acalabrutinib and R-CHOP for Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Acalabrutinib
    Italy

  • Study of [90Y]Y-PentixaTher and [68Ga]Ga-PentixaFor in patients with advanced Non-Hodgkin lymphomas: Evaluating radiopeptide-based imaging and therapy

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Pentixather
    • Yttrium-90
    • Pentixafor
    Germany

  • Study on Magnesium Sulfate and Ropivacaine for Pain Relief in Knee Replacement Surgery Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Knee arthroplasty
    Investigated Drugs:
    • Magnesium Sulfate
    • Ropivacaine Hydrochloride
    • Saline
    Spain

  • Study on the Effects of Ferric Derisomaltose and Dopaminergic Therapy for Patients with Restless Legs Syndrome

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Ferric Derisomaltose
    • Sodium Chloride
    Austria

  • Study on Oral and Enema Fecal Microbiota Transplantation for Children with Ulcerative Colitis

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    France

  • Study on the Effects of Dapagliflozin on Heart Function in Patients with Chronic Kidney Disease

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Dapagliflozin Propanediol
    Denmark
Previous Page
1 … 902 903 904 905 906 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!